Rosetta Genomics (ROSGQ) Stock Price, News & Analysis

Company Overview

Rosetta Genomics is a molecular diagnostics company that develops and commercializes tests based on microRNA biomarkers for oncology and other disease areas. Leveraging proprietary platforms for microRNA discovery and quantification, the company’s products aim to enhance the accuracy of disease diagnosis, prognosis and therapeutic guidance. Its technology is designed to work with a variety of sample types, including formalin-fixed, paraffin-embedded (FFPE) tissue, blood and fine-needle aspirates, enabling broad clinical applicability.

Founded in 2003 and headquartered in Rehovot, Israel, Rosetta Genomics operates a CLIA-certified laboratory in the United States and maintains research and development activities at its Israeli site. The company collaborates with academic centers, medical institutions and pharmaceutical companies to advance microRNA-based biomarker research. Through these partnerships, it seeks to develop companion diagnostics that align targeted therapies with patients most likely to benefit from treatment.

Rosetta’s test menu includes assays for various solid tumors, such as lung, colorectal and melanoma cancers, providing clinicians with information to differentiate tumor types and predict patient outcomes. By focusing on microRNA signatures—short, non-coding RNA molecules that regulate gene expression—the company offers a novel approach to biomarker discovery that complements existing genomic and proteomic methods. Rosetta continues to expand its diagnostic pipeline and explore new indications where microRNA profiling may improve clinical decision-making.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 7/20/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:ROSGQ
• CIK: N/A
• Web: www.rosettagenomics.com
• Phone: 972732220700
• Fax: 972-73-222-0701
• Employees: 86
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -5.47